Single 5mg vial GLP1
All products spoken about or shown are not intended for human consumption in any way. Products listed are offered for use in research only and should not be for human use.
GLP1
(GLP-1 Analogue)
GLP1, derived from the naturally occurring GLP-1 peptide, has demonstrated the ability to lower blood sugar levels and boost insulin secretion. Beyond its glucose-regulating effects, research suggests that Semaglutide may have broader health benefits, including improvements in heart, liver, and lung function, and potential efficacy in slowing or preventing the onset of Alzheimer’s disease. One notable effect of Semaglutide is its significant reduction in appetite, achieved by delaying gastric emptying and reducing intestinal motility. This GLP-1 analog has also been shown to stimulate insulin production and inhibit glucagon secretion in a glucose-dependent manner.
THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.
GLP-1 Overview
GLP-1, or glucagon-like peptide-1, is a concise peptide hormone composed of just 30-31 amino acids. Its primary physiological function revolves around the regulation of blood sugar levels by naturally enhancing insulin secretion. Moreover, it contributes to the protection of insulin stores in beta cells by promoting the transcription of insulin genes. Additionally, GLP-1 is associated with neurotrophic effects in the brain and central nervous system. In the gastrointestinal system, GLP-1 is known to have a significant appetite-reducing effect by slowing down gastric emptying and decreasing intestinal motility. Emerging research has also revealed potential impacts of GLP-1 in various organs, including the heart, fat tissue, muscles, bones, liver, lungs, and kidneys.
The predominant focus of GLP-1 research has been on its applications in the realm of diabetes treatment and prevention, as well as its ability to suppress appetite. Secondary areas of research explore the potential cardiovascular benefits of this peptide. More recent studies, though less extensive, have been concentrating on the potential of GLP-1 to mitigate neurodegenerative diseases. This particular area of research is gaining momentum, especially since GLP-1 has shown promise in slowing down or preventing the accumulation of amyloid beta plaques associated with Alzheimer’s disease.
Structure
Sequence: HXEGTFTSDVSSYLEGQAAK-OH.steric diacid-EFIAWLVRGRG
Molecular Formula: C187H291N45O59
Molecular Weigh: 4113.64 g/mol
PubChem CID: 56843331
CAS Number: 910463-68-2
Synonyms: Semaglutide, Oxempic, Rybelsus, NN9535
In dog studies, large infusions of GLP-1 have been shown to enhance left ventricular performance and decrease systemic vascular resistance. This reduction in blood pressure and relief on the heart can help mitigate the long-term consequences of high blood pressure, such as left ventricular remodeling, vascular thickening, and heart failure. According to Dr. Holst, administering GLP-1 following cardiac injury consistently improves myocardial performance in both experimental animal models
GLP-1 is associated with minimal to moderate side effects, excellent subcutaneous bioavailability in mice, and low oral bioavailability. GLP-1 is available for research purposes only and should not be consumed by humans without the appropriate research licensing. If you wish to purchase GLP-1, ensure that you are a researcher.
GLP1 mimics the action of the natural hormone GLP-1, which plays a crucial role in regulating appetite and food intake in research subjects.
Clinical studies have demonstrated that Semaglutide significantly aids in weight loss, with participants experiencing substantial reductions in body weight over a sustained period. By enhancing feelings of fullness and reducing hunger,
Reviews
There are no reviews yet.